Welcome to our dedicated page for Daktronics SEC filings (Ticker: DAKT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Daktronics Inc. filings document the public-company disclosures of an operating manufacturer of electronic display systems and control technologies. Recent Form 8-K reports cover operating and financial results, material definitive agreements, governance and management changes, executive compensation arrangements, shareholder voting matters and capital-structure disclosures.
The filing record also includes disclosures tied to cooperation agreement amendments, leadership transition terms, equity award treatment, common stock ownership information, and exhibits furnished with earnings releases. These documents frame the company’s reporting around results, governance, contractual obligations and securities-related matters.
Reece A. Kurtenbach, a director of Daktronics, reported receiving 25,211 shares of Daktronics common stock as a gift from a grantor retained annuity trust on 08/21/2025 at a reported price of $0. After the transaction, Kurtenbach beneficially owns 587,946 shares directly. The filing also discloses 17,400 shares held indirectly by the reporting person’s spouse. The Form 4 was signed by Reece A. Kurtenbach on 09/19/2025 and indicates the acquisition was reported under transaction code G for a gift.
Reece A. Kurtenbach, a director of Daktronics, reported receiving 25,211 shares of Daktronics common stock as a gift from a grantor retained annuity trust on 08/21/2025 at a reported price of $0. After the transaction, Kurtenbach beneficially owns 587,946 shares directly. The filing also discloses 17,400 shares held indirectly by the reporting person’s spouse. The Form 4 was signed by Reece A. Kurtenbach on 09/19/2025 and indicates the acquisition was reported under transaction code G for a gift.
Matthew J. Kurtenbach, VP of Manufacturing at Daktronics, reported receipt of 25,211 shares of Daktronics common stock as a gift on 08/21/2025. The Form 4 shows the shares were received at a $0 price from a grantor retained annuity trust and increased his reported beneficial ownership to 310,102.7 shares. The filing also discloses 5,000 shares held indirectly by a trust for the benefit of his child and 21,000 shares held in three UTMA custodial accounts for his children, where he serves as trustee/custodian. The filing includes a legal disclaimer that he disclaims beneficial ownership except to the extent of any pecuniary interest.
Matthew J. Kurtenbach, VP of Manufacturing at Daktronics, reported receipt of 25,211 shares of Daktronics common stock as a gift on 08/21/2025. The Form 4 shows the shares were received at a $0 price from a grantor retained annuity trust and increased his reported beneficial ownership to 310,102.7 shares. The filing also discloses 5,000 shares held indirectly by a trust for the benefit of his child and 21,000 shares held in three UTMA custodial accounts for his children, where he serves as trustee/custodian. The filing includes a legal disclaimer that he disclaims beneficial ownership except to the extent of any pecuniary interest.
Insider transactions at Daktronics, Inc. (DAKT)
On 09/17/2025 Carla S. Gatzke, Secretary and VP of Human Resources and an officer of Daktronics, reported multiple transactions involving incentive stock options and common stock. Ms. Gatzke was the recipient of four groups of incentive stock options on 09/17/2025 totaling 25,240 options exercisable into common stock at prices of $9.57, $9.63, $7.83 and $7.47; each option group has zero shares outstanding following the reported transaction. The filing also discloses a sale of 9,944 shares of common stock at $23.0892 per share. Following the reported transactions, Ms. Gatzke directly beneficially owns 721,036 shares, and indirectly holds 183,376 shares via a 401(k).
Insider transactions at Daktronics, Inc. (DAKT)
On 09/17/2025 Carla S. Gatzke, Secretary and VP of Human Resources and an officer of Daktronics, reported multiple transactions involving incentive stock options and common stock. Ms. Gatzke was the recipient of four groups of incentive stock options on 09/17/2025 totaling 25,240 options exercisable into common stock at prices of $9.57, $9.63, $7.83 and $7.47; each option group has zero shares outstanding following the reported transaction. The filing also discloses a sale of 9,944 shares of common stock at $23.0892 per share. Following the reported transactions, Ms. Gatzke directly beneficially owns 721,036 shares, and indirectly holds 183,376 shares via a 401(k).
Form 144 notice for DAKT reporting a proposed sale of 9,944 common shares acquired and to be sold on 09/17/2025. The shares were obtained that same day through a stock option exercise from the issuer and payment was made in cash. The filer lists an aggregate market value of $229,599.00 for the shares and reports 48,530,238 shares outstanding for the class. The intended sale is through Morgan Stanley Smith Barney LLC on NASDAQ. The filer indicates no securities sold in the past three months and includes the standard attestation about absence of undisclosed material information.
Andrew D. Siegel, a director of Daktronics, acquired 3,535 restricted shares on 09/15/2025 at $24.04 per share. After the transaction he beneficially owns 46,981 shares directly and 163,345 shares indirectly through Prairieland Holdco, LLC. The restricted stock vests one year from the grant date. The filing states Mr. Siegel is the sole member and president of the manager of Prairieland Holdco, LLC, which explains the indirect ownership. This Form 4 reports an insider purchase and provides the vesting condition for the newly acquired shares.
DAKT Form 4: Director Lance D. Bultena reported an acquisition of 3,535 shares of Daktronics Inc. common stock on 09/15/2025 at a reported price of $24.04 per share. After this transaction he beneficially owns 47,040 shares. The reported shares are restricted stock that vests one year from the grant date, per the form's explanation. The filing identifies Mr. Bultena as a director and was signed on 09/16/2025.
Peter Feigin, a director of Daktronics Inc. (DAKT), reported acquiring 3,535 shares of the issuer's common stock on 09/15/2025 at a price of $24.04 per share. The filing shows these shares are restricted stock that vests one year from the grant date. After the transaction, Feigin beneficially owns 10,356 shares in total. The Form 4 is signed 09/16/2025 and indicates the report was filed by one reporting person.
John P. Friel, a director of Daktronics Inc. (DAKT), reported both a sale and a grant on 09/15/2025. He sold 13,479 shares of common stock at $23.5812 per share, and received a grant of 3,535 restricted shares at an indicated price of $24.04 that vest one year from the grant date. After these transactions his reported beneficial ownership is 77,629 shares (direct).
The Form 4 shows the sale reduced liquidity holdings but the restricted stock award increases his long-term stake subject to vesting. All details are presented as reported; no additional context, motives, or company guidance is included in the filing.
Insider acquisition reported: Shereta D. Williams, a director of Daktronics, acquired 3,535 shares of the company's common stock on 09/15/2025 at a price of $24.04 per share. After the transaction, Williams beneficially owns 47,040 shares. The reported shares are restricted stock that will vest one year from the grant date. The Form 4 was signed on 09/16/2025 and indicates the filing was made by one reporting person.
Jose-Marie Griffiths, a director of Daktronics, acquired 3,535 shares of common stock on 09/15/2025 at $24.04 per share, increasing her direct beneficial ownership to 61,030 shares. The acquisition is recorded as restricted stock that vests one year from the grant date, indicating the shares are subject to time-based vesting and not immediately transferable. The Form 4 shows the reporting person filed as an individual director and discloses no derivative transactions.
This filing documents an insider purchase rather than a sale, which can signal confidence by management, but the form does not provide company financial results or further context on the grant's purpose.